June 15, 2022

Oversight of the Office of National Drug Control Policy (ONDCP) and its 2022 National Drug Control Strategy

Washington, DC – At 2 p.m. on Wednesday, June 15, the Senate Caucus on International Narcotics Control held a hearing entitled, “Oversight of the Office of National Drug Control Policy (ONDCP) and its 2022 National Drug Control Strategy,” in Room 608 of the Dirksen Senate Office Building.  The hearing examined the National Drug Control Strategy and its compliance with ONDCP’s statutory authorization.

The hearing transcript is available here.

Opening Statements

CHAIRMAN (D - RI)

Sheldon Whitehouse

Sen. Whitehouse’s opening statement, as prepared for delivery.

CO-CHAIR (R - IA)

Chuck Grassley

Sen. Grassely’s opening statement, as prepared for delivery.

Witnesses

Rahul Gupta

MD, MPH, MBA, FACP, Director, ONDCP

Panel II

Triana McNeil

Director, Strategic Issues, Government Accountability Office

NNOAC Statement for the Record available here.

RAND Statement for the Record available here.

NHDA Statement for the Record available here.

ONDCP’s Responses to Questions for the Record available here.